Personalised medicine has, over recent years, made the transition from ambition to reality. It moves healthcare from taking a one-size-fits-all or blunt approach to something far more responsive and tailored.
Essentially, it involves stratifying patients according to a range of factors – from broad categories such as risk profile, disease subsets and responses to particular diagnostic tests, through to highly individualised profiling based on factors like molecular and behavioural markers – and applying treatments tailored precisely to those profiles.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.
